Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation

Open access
Tsien, Cynthia, Garber, Ari, Narayanan, Arvind, Shah, Shetal N, Barnes, David, Eghtesad, Bijan, Fung, John, McCullough, Arthur J, Dasarathy, Srinivasan · 2014 · Journal of Gastroenterology and Hepatology

Abstract

Background and Aim: Pre‐transplant sarcopenia (reduced skeletal muscle mass) predicts poor outcome in cirrhosis. In contrast, whether muscle mass increases post‐orthotopic liver transplantation (OLT) is not known and was studied prospectively. Methods: Consecutive patients who underwent a comprehensive nutritional evaluation in a liver transplant nutrition clinic were included. Core abdominal muscle area was measured on abdominal computed tomography obtained pre‐ and post‐OLT. Age‐ and gender‐based controls were used to define sarcopenia. Measures of body composition pre‐transplant were correlated with computed tomography measurements. Predictors and clinical impact of post‐OLT change in muscle area were examined. In three subjects post‐OLT and three controls, expression of genes regulating skeletal muscle mass were quantified. Results: During the study period, 53 patients (M:F 41:12; age 56.9 ± 7.5 years) were followed up after OLT for 19.3 ± 9 months. Five patients died and another five had acute graft rejection. Pre‐OLT sarcopenia was present in 33 (66.2%). Pre‐transplant clinical characteristics including C hild's score, MELD score, and nutritional status or post‐transplantation immunosuppression regimen did not predict post‐transplant change in muscle mass. New onset post‐OLT sarcopenia developed in 14 patients. Loss of muscle mass post‐OLT increased risk of diabetes mellitus and a trend toward higher mortality. Skeletal muscle expression of myostatin was higher and that of ubiquitin proteasome proteolytic components lower post‐OLT than in controls. Conclusions: Post‐transplantation sarcopenia is common and could not be attributed to pre‐transplant characteristics or the type or duration of post‐OLT immunosuppression. Post‐transplant sarcopenia contributes to adverse consequences and strategies targeting myostatin may be beneficial.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgh.12524

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 179

Metadata

Authors
Tsien, C., Garber, A., Narayanan, A., Shah, S. N., Barnes, D., Eghtesad, B., Fung, J., McCullough, A. J., & Dasarathy, S.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2014-05-15
Volume
29
Issue
6
Pages
1250-1257
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W1590977658
Cited by
179
References
5
FWCI
7.97
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation. https://app.cochat.ai/papers/10.1111/jgh.12524
The paper
Tsien, C., Garber, A., Narayanan, A., Shah, S. N., Barnes, D., Eghtesad, B., Fung, J., McCullough, A. J., & Dasarathy, S. (2014). Post‐liver transplantation sarcopenia in cirrhosis: A prospective evaluation. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.12524

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.